Benitec Biopharma Inc.
NASDAQ:BNTCBiotechnology
+$0.36 today
- Market cap
- $288.53M
- Beta
- 0.28
- P/E (TTM)
- -12.3
- EPS (TTM)
- -$0.99
Volume 0.13M
Average 0.11M
BNTC Long-term Investments
Investments the company intends to hold for more than a year.
Benitec Biopharma Inc.NASDAQ: BNTC
Long-term Investments · Q3 FY2026 · quarter ended Mar 2026
Long-term investments remains negative
Q3 FY2026 long-term investments was $0, compared with $0 a year earlier.
Context
- Long-term investments amounted to 0.0% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
- Long-term investments increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Long-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 0 | — |
| FY2024 | 2024-06-30 | 0 | — |
| FY2023 | 2023-06-30 | 0 | — |
| FY2022 | 2022-06-30 | 0 | — |
| FY2021 | 2021-06-30 | 0 | — |
Long-term Investments vs competitors
How BNTC compares with its peers on the latest reported figures
- BNTC's Mar 2026 long-term investments of $0 is the 7th highest of the 10 companies compared; the peer median is $537K.
- Long-term investments amounts to 0.0% of total assets for BNTC, versus a peer median of 0.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $217.43M | +8.6% | +52.9% | 40.7% | |
| Mar 2026 | $105.11M | — | +18.7% | 38.7% | |
| Mar 2026 | $63.02M | — | — | 29.5% | |
| Mar 2026 | $708K | — | — | 0.2% | |
| Mar 2026 | $537K | — | — | 0.5% | |
| Mar 2026 | $318K | — | — | 0.6% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding BNTC) | $537K | +8.6% | +35.8% | 0.5% | |
Competitors are the stored peer set for BNTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Benitec Biopharma Inc.
NASDAQ:BNTC
Intrinsic Alpha fair value
Locked
Current Price
$8.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.